ÂÜÀòÂÒÂ×

Scott Zingheim has a diverse work experience spanning different industries. Scott is currently a Co-Founder and Chief Operating Officer at Cellibre since July 2019. Prior to that, they were the Head of Corporate Development and Strategy at Synthetic Genomics from May 2016 to August 2018.

Before joining Synthetic Genomics, Scott worked as an Associate in Healthcare Investment Banking at J.P. Morgan from October 2013 to May 2016. Scott also served as an Analyst in Investment Banking at Houlihan Lokey from July 2012 to October 2013.

Scott's early career includes a role as an Accounting & Pricing Specialist at State Street Bank from January 2010 to June 2012. Overall, their work experience showcases a strong background in corporate development, strategy, and investment banking.

Scott Zingheim attended Loyola Marymount University from 2005 to 2009, where they obtained a Bachelor of Arts degree in Economics and Finance. Prior to attending university, Scott Zingheim also attended Granite Bay HS, although no degree or field of study information was provided for this educational institution.